ATLANTA, GA—In a finding that sheds some light on just how semaglutide helps the heart, patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes see ...

(RTTNews) - Novo Nordisk (NVO) reported headline results from STEP UP, a phase 3b trial in the global STEP programme. The trial achieved primary endpoint by demonstrating a statistically significant ...

A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over ...

Clinical trials are an essential part of improving stroke care for patients, but each trial can also require years of planning and tens of millions of dollars from start to finish. Two University of ...

DALLAS -- People taking antidepressants lost a similar amount of weight on semaglutide 2.4 mg (Wegovy) compared with those not taking antidepressants, according to a post-hoc analysis of four STEP ...

When researchers pooled data from six major clinical trials of semaglutide, the drug behind Ozempic and Wegovy, they found something that had been hoped for but never confirmed at this scale: adults ...

Credit: Getty Images Until semaglutide, weight loss of 15% to avoid obesity-related complications was only achieved through bariatric surgery. In clinical trials, semaglutide proved to be superior to ...